Paper Details

  1. Home
  2. Paper Details

Therapy with zoledronic acid, 5 mg, for a patient with Paget disease of bone.

Author: TucciJoseph R

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

A single 5 mg infusion of zoledronic acid induced a sustained remission lasting 20 months in a patient with Paget disease of bone who had not responded well to other bisphosphonates. Zoledronic acid was well-tolerated and significantly decreased bone pain.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To describe the effects of an infusion of zoledronic acid in a patient with Paget disease of bone (PD) who had been treated unsuccessfully with several other bisphosphonates. METHODS: The patient's treatment history is described, and his response to various bisphosphonates, including zol...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.4158/EP.14.5.607

データ提供：米国国立医学図書館（NLM）

Zoledronic Acid: A Powerful Oasis for Paget's Disease

Paget's disease, a chronic bone disorder, often presents a challenging clinical landscape. This study examines the efficacy of zoledronic acid, a powerful bisphosphonate, in managing this condition. The researchers, like skilled desert navigators, navigate the complexities of Paget's disease, seeking a treatment that can effectively address the patient's needs.

Zoledronic Acid: A Beacon of Hope for Paget's Disease

This study reveals the effectiveness of zoledronic acid in treating Paget's disease. The research highlights the potential for longer-lasting remissions with zoledronic acid, offering a valuable alternative for patients who have not responded well to other bisphosphonates. This is like discovering a hidden oasis in a parched desert, providing much-needed relief from the symptoms of Paget's disease.

Navigating the Treatment Landscape: Choosing the Right Path

The study emphasizes the importance of considering the relative efficacy of different bisphosphonates. It highlights the potential benefits of zoledronic acid for patients who have not responded to other treatments. This is akin to choosing the most effective route through a challenging desert terrain, ensuring the best possible outcome for the patient.

Dr. Camel's Conclusion

This research offers a valuable roadmap for navigating the treatment landscape of Paget's disease. It underscores the importance of individualizing treatment based on the patient's specific needs and response. This study provides a beacon of hope for patients struggling with Paget's disease, demonstrating the potential for effective and long-lasting relief.

Date :
  1. Date Completed 2009-01-14
  2. Date Revised 2021-02-04
Further Info :

Pubmed ID

18753106

DOI: Digital Object Identifier

10.4158/EP.14.5.607

Related Literature

Article Analysis
・Side Effects of etidronate
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.